Product Description

Bonspri Injection contains the active ingredient Ofatumumab, belonging to the class of medicines known as monoclonal antibodies. It is indicated to treat adult patients having relapsing forms of multiple sclerosis (RMS). Inform your doctor if you have any immune system problems, cancer, or any severe infection or if you are planning on getting vaccinated before starting treatment with this medication. If you have or had hepatitis B infection, then inform your doctor before you start treatment with this medication as this medication might cause the hepatitis B virus to become active again. 
 

Effective contraception is to be followed while using Bonspri Injection and is to be used for up to six months from the last dose of this medication. Inform your doctor if you get pregnant while using this medication or within six months from the last dose. Upper respiratory tract infections, decrease in the level of immunoglobulin M protein in the blood, oral herpes, pain or itching or redness or swelling at the injection site are some common side effects of this medication.  

How to use

Use as directed

Uses

Treatment of Multiple Sclerosis

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
 

The side effects of Bonspri Injection are listed below:
 

Common:

• Upper respiratory tract infections (sore throat and runny nose)
• Urinary tract infections
• Decrease in the level of immunoglobulin M protein in the blood
• Oral herpes
• Pain, redness, swelling and itching at injection site.

Storage

Do not freeze.Store in a refrigerator 2 - 8℃